ABBVIE DEUTSCHLAND GMBH & CO KG - DE 

This institution has been merged with: ABBVIE INC.

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 20.000.000 0 2
2016 0 12.348.000 0 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV3
ASTRAZENECA AB2
ELI LILLY AND COMPANY LIMITED2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
ORION OYJ2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
UNIVERSITEIT LEIDEN2
ACADEMISCH ZIEKENHUIS GRONINGEN1
ANTAROS MEDICAL AB1
ARTTIC1
AXXAM1
BAYER PHARMA1
BIOGEN IDEC LIMITED1
BIOXYDYN LIMITED1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRUKER BIOSPIN MRI1
CAEBI BIOINFORMATICA SOCIEDAD LIMITADA1
CERTARA UK LIMITED1
CHALMERS TEKNISKA HOEGSKOLA AB1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
DC BIOSCEINCES1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
EISAI LIMITED1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
F HOFFMANNLA ROCHE1
FORSCHUNGSGESELLSCHAFT FUR ARBEITSPHYSIOLOGIE UND ARBEITSSCHUTZ E V1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO ACE1
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM1
GE HEALTHCARE LIMITED1
GOETEBORGS UNIVERSITET1
H LUNDBECK AS1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER1
KING'S COLLEGE LONDON1
KITE INNOVATION LIMITED1
KLINIKUM DER UNIVERSITAET ZU KOELN1
LIFE AND BRAIN1
LUNDS UNIVERSITET1
MERCK SHARP & DOHME CORP1
MIMETAS BV1
MODUS RESEARCH AND INNOVATION LIMITED1
NOVO NORDISK1
OCELLO BV1
PFIZER LIMITED1
SANOFIAVENTIS DEUTSCHLAND1
STICHTING KATHOLIEKE UNIVERSITEIT1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF MANCHESTER1
THE UNIVERSITY OF SHEFFIELD1
TRULY LABS AB1
UNIVERSITAETSKLINIKUM AACHEN1
UNIVERSITAETSKLINIKUM BONN1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITAT WIEN1
UNIVERSITATSKLINIKUM BONN1
UNIVERSITE DE BOURGOGNE1
UNIVERSITEIT MAASTRICHT1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF LEEDS1

Constancy:

Total number of partners: 74
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 71
Frequent / Rare Partner Ratio: 0.04

Project overview:

Start dateProjectacronymrolefundingpartners
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975 ADAPTEDparticipant3.510.00014